Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Debt / NOTE 2.000% 3/1
-
Market price (% of par)
-
105.6%
-
Total 13F principal
-
$320,190,500
-
Principal change
-
+$317,215,500
-
Total reported market value
-
$339,259,650
-
Number of holders
-
35
-
Value change
-
+$336,119,251
-
Number of buys
-
34
Institutional Holders of AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 as of Q3 2024
As of 30 Sep 2024,
AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 was held by
35 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$320,190,500
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, READYSTATE ASSET MANAGEMENT LP, MACKAY SHIELDS LLC, CAMDEN ASSET MANAGEMENT L P /CA, WOLVERINE ASSET MANAGEMENT LLC, Wellesley Asset Management, BRAIDWELL LP, SHENKMAN CAPITAL MANAGEMENT INC, Calamos Advisors LLC, and SSI INVESTMENT MANAGEMENT LLC.
This page lists
35
institutional bondholders reporting positions
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.